EUCTR2012-001757-21-IT进行中（未招募）1 期
European Society of Hypertension and Chinese Hypertension League stroke in hypertension optimal treatment trial - Stroke in hypertension optimal treatment
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 7,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Stroke or transient ischemic attack 1 to 6 months previous to randomization; - 65 years and above; - Only hypertensive patients; - Patients without statin treatment with LDL-cholesterol > 2.8 mmol/l; - Patients on statin treatment with any LDL-cholesterol value
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 7500
排除标准
- •- Patients in unstable clinical conditions; - Patients with haemodynamically significant carotid stenosis or requiring carotid revascularization.
研究者
相似试验
进行中（未招募）
1 期
ESH-CHL-SHOT: Blood pressure lowering and lipid lowering treatment after strokePatients with previous stroke (or transient ischaemic attack) and hypertension and hyperlipidaemia.EUCTR2012-001757-21-SEIstituto Auxologico Italiano7,500
已完成
4 期
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in HypertensivesStrokeHypertensionTransient Ischemic AttackNCT01563731Istituto Auxologico Italiano200
撤回
不适用
eo* Randomized Hypertension Studyrefractory high blood pressuretherapy-resistant hypertension10057166NL-OMON37975CVRx Inc25
招募中
不适用
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"HypertensionNCT04289701Chinese Academy of Medical Sciences, Fuwai Hospital200,000
Unknown
不适用
The Chinese Early-onset Hypertension Study (CHESS)HypertensionNCT02819674China National Center for Cardiovascular Diseases5,000